Key Statistics
Market Cap$8.56B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$2.90
52W High$228.88
52W Low$91.86
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
Employees19,700
Price Performance
1 Week+9.25%
3 Month-16.53%
1 Year+23.34%
FinancialsAnnual · QuiverQuant
Revenue$4.13B
Assets$8.20B
Liabilities$4.54B
Net Income$480.37M
About
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CRL with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.